LEPR and neoplasm: We could also show that leptin activates potent oncogenic pathways depending on JAK2/STAT3, AKT and ERK1/2 in the tumor cell line that carried a high-copy amplicon on the locus of the leptin receptor (Supplementary Figure 5).